- Home
- OSW vs JANX Comparison
OSW vs JANX Comparison
Compare OSW & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSW
- JANX
- Stock Information
- Founded
- OSW 2017
- JANX 2017
- Country
- OSW Bahamas
- JANX United States
- Employees
- OSW N/A
- JANX N/A
- Industry
- OSW Hotels/Resorts
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- OSW Consumer Discretionary
- JANX Health Care
- Exchange
- OSW Nasdaq
- JANX Nasdaq
- Market Cap
- OSW 1.9B
- JANX 1.6B
- IPO Year
- OSW N/A
- JANX 2021
- Fundamental
- Price
- OSW $18.86
- JANX $23.80
- Analyst Decision
- OSW Strong Buy
- JANX Strong Buy
- Analyst Count
- OSW 4
- JANX 7
- Target Price
- OSW $20.75
- JANX $94.29
- AVG Volume (30 Days)
- OSW 514.1K
- JANX 1.3M
- Earning Date
- OSW 07-30-2025
- JANX 05-08-2025
- Dividend Yield
- OSW 0.85%
- JANX N/A
- EPS Growth
- OSW 84.76
- JANX N/A
- EPS
- OSW 0.63
- JANX N/A
- Revenue
- OSW $903,423,000.00
- JANX $9,336,000.00
- Revenue This Year
- OSW $7.36
- JANX N/A
- Revenue Next Year
- OSW $8.44
- JANX $283.88
- P/E Ratio
- OSW $29.89
- JANX N/A
- Revenue Growth
- OSW 9.80
- JANX 28.12
- 52 Week Low
- OSW $14.21
- JANX $22.48
- 52 Week High
- OSW $23.01
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- OSW 54.59
- JANX 39.00
- Support Level
- OSW $18.45
- JANX $23.52
- Resistance Level
- OSW $19.30
- JANX $26.46
- Average True Range (ATR)
- OSW 0.44
- JANX 1.79
- MACD
- OSW -0.06
- JANX -0.00
- Stochastic Oscillator
- OSW 46.92
- JANX 27.53
About OSW OneSpaWorld Holdings Limited
OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts all over the world. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.